Controlled dual delivery of BMP-2 and dexamethasone by nanoparticle-embedded electrospun nanofibers for the efficient repair of critical-sized rat calvarial defect.
暂无分享,去创建一个
Shan Ding | Yi Wang | Shaobing Zhou | Shaobing Zhou | S. Ding | Long Li | Guang Yang | Yi Wang | Guang Yang | Guangliang Zhou | Long Li | Guangliang Zhou
[1] S. Cramer. Marrow-Derived Mesenchymal Stromal Cells in the Treatment of Stroke , 2016 .
[2] Y. Tabata,et al. Stimulation of bone regeneration following the controlled release of water-insoluble oxysterol from biodegradable hydrogel. , 2014, Biomaterials.
[3] Jiang Chang,et al. Silicate bioceramics enhanced vascularization and osteogenesis through stimulating interactions between endothelia cells and bone marrow stromal cells. , 2014, Biomaterials.
[4] J. Werkmeister,et al. Bone regeneration using photocrosslinked hydrogel incorporating rhBMP-2 loaded 2-N, 6-O-sulfated chitosan nanoparticles. , 2014, Biomaterials.
[5] Changsheng Liu,et al. Vascularization and bone regeneration in a critical sized defect using 2-N,6-O-sulfated chitosan nanoparticles incorporating BMP-2. , 2014, Biomaterials.
[6] Shaobing Zhou,et al. Co-delivery of Dexamethasone and Green Tea Polyphenols Using Electrospun Ultrafine Fibers for Effective Treatment of Keloid , 2014, Pharmaceutical Research.
[7] Shaobing Zhou,et al. Synergistic effect of released dexamethasone and surface nanoroughness on mesenchymal stem cell differentiation. , 2013, Biomaterials science.
[8] W. Cui,et al. Tendon healing and anti-adhesion properties of electrospun fibrous membranes containing bFGF loaded nanoparticles. , 2013, Biomaterials.
[9] B. Ding,et al. Biomimetic electrospun nanofibrous structures for tissue engineering. , 2013, Materials today.
[10] Ralph Müller,et al. Low dose BMP-2 treatment for bone repair using a PEGylated fibrinogen hydrogel matrix. , 2013, Biomaterials.
[11] W. Tan,et al. Effect of porosity on long-term degradation of poly (ε-caprolactone) scaffolds and their cellular response , 2013 .
[12] Wenxin Wang,et al. Encapsulation and 3D culture of human adipose-derived stem cells in an in-situ crosslinked hybrid hydrogel composed of PEG-based hyperbranched copolymer and hyaluronic acid , 2013, Stem Cell Research & Therapy.
[13] Georg N Duda,et al. Biomaterial delivery of morphogens to mimic the natural healing cascade in bone. , 2012, Advanced drug delivery reviews.
[14] Shaobing Zhou,et al. Modulating cellular behaviors through surface nanoroughness , 2012 .
[15] Chaoyang Wang,et al. Chitosan nanoparticles as particular emulsifier for preparation of novel pH-responsive Pickering emulsions and PLGA microcapsules , 2012 .
[16] S. Ramakrishna,et al. Controlled release of bone morphogenetic protein 2 and dexamethasone loaded in core-shell PLLACL-collagen fibers for use in bone tissue engineering. , 2012, Acta biomaterialia.
[17] Ahmed O Elzoghby,et al. Albumin-based nanoparticles as potential controlled release drug delivery systems. , 2012, Journal of controlled release : official journal of the Controlled Release Society.
[18] C. Deng,et al. TGF-β and BMP Signaling in Osteoblast Differentiation and Bone Formation , 2012, International journal of biological sciences.
[19] Cato T Laurencin,et al. Bone tissue engineering: recent advances and challenges. , 2012, Critical reviews in biomedical engineering.
[20] S. Tangl,et al. The effect of BMP-2 on the osteoconductive properties of β-tricalcium phosphate in rat calvaria defects. , 2011, Biomaterials.
[21] Shaobing Zhou,et al. Osteoblast function on electrically conductive electrospun PLA/MWCNTs nanofibers. , 2011, Biomaterials.
[22] Eyal Zussman,et al. Slow-release human recombinant bone morphogenetic protein-2 embedded within electrospun scaffolds for regeneration of bone defect: in vitro and in vivo evaluation. , 2011, Tissue engineering. Part A.
[23] Yan Sun,et al. Bioactive Electrospun Scaffolds Delivering Growth Factors and Genes for Tissue Engineering Applications , 2010, Pharmaceutical Research.
[24] Nuno M Neves,et al. Osteogenic induction of hBMSCs by electrospun scaffolds with dexamethasone release functionality. , 2010, Biomaterials.
[25] Franz Jakob,et al. Autocrine fibroblast growth factor 18 mediates dexamethasone‐induced osteogenic differentiation of murine mesenchymal stem cells , 2010, Journal of cellular physiology.
[26] K. Popat,et al. Bone tissue engineering: A review in bone biomimetics and drug delivery strategies , 2009, Biotechnology progress.
[27] Hae-Won Kim,et al. Electrospun materials as potential platforms for bone tissue engineering. , 2009, Advanced drug delivery reviews.
[28] H. Uludaǧ,et al. Pharmacokinetics and bone formation by BMP-2 entrapped in polyethylenimine-coated albumin nanoparticles. , 2009, Biomaterials.
[29] A. Lendlein,et al. Knowledge‐Based Approach towards Hydrolytic Degradation of Polymer‐Based Biomaterials , 2009, Advanced materials.
[30] Michael J Yaszemski,et al. Effect of local sequential VEGF and BMP-2 delivery on ectopic and orthotopic bone regeneration. , 2009, Biomaterials.
[31] J. Fischer,et al. Dexamethasone modulates BMP‐2 effects on mesenchymal stem cells in vitro , 2008, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.
[32] W. Lu,et al. Development and evaluation of novel itraconazole-loaded intravenous nanoparticles. , 2008, International journal of pharmaceutics.
[33] R. Zernicke,et al. Preparation of BMP-2 Containing Bovine Serum Albumin (BSA) Nanoparticles Stabilized by Polymer Coating , 2008, Pharmaceutical Research.
[34] D. Bikiaris,et al. Chitosan nanoparticles loaded with dorzolamide and pramipexole , 2008 .
[35] R. Lenkinski,et al. Choline Autoradiography of Human Prostate Cancer Xenograft: Effect of Castration , 2008, Molecular Imaging.
[36] R. Lenkinski,et al. Humoral Bone Morphogenetic Protein 2 Is Sufficient for Inducing Breast Cancer Microcalcification , 2008, Molecular imaging.
[37] H. Jennissen,et al. Polyethylenimine‐coated albumin nanoparticles for BMP‐2 delivery , 2008, Biotechnology progress.
[38] Koichi Matsuo,et al. Osteoclast-osteoblast communication. , 2008, Archives of biochemistry and biophysics.
[39] Molly M. Stevens,et al. Biomaterials for bone tissue engineering , 2008 .
[40] K. Omura,et al. Effects of continuous dexamethasone treatment on differentiation capabilities of bone marrow-derived mesenchymal cells. , 2007, Bone.
[41] O. Barbier,et al. Bone allografts: What they can offer and what they cannot. , 2007, The Journal of bone and joint surgery. British volume.
[42] S. Mann,et al. An ex vivo model for chondrogenesis and osteogenesis. , 2007, Biomaterials.
[43] E. Langenfeld,et al. Bone morphogenetic protein 2 stimulation of tumor growth involves the activation of Smad-1/5 , 2006, Oncogene.
[44] Julian R Jones,et al. Hierarchical porous materials for tissue engineering , 2006, Philosophical Transactions of the Royal Society A: Mathematical, Physical and Engineering Sciences.
[45] Y. Tabata,et al. Enhanced osteoinduction by controlled release of bone morphogenetic protein-2 from biodegradable sponge composed of gelatin and beta-tricalcium phosphate. , 2005, Biomaterials.
[46] C. Remuñán-López,et al. Microencapsulated chitosan nanoparticles for lung protein delivery. , 2005, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[47] S. Hollister. Porous scaffold design for tissue engineering , 2005, Nature materials.
[48] R. Bizios,et al. Engineering bone: challenges and obstacles , 2005, Journal of cellular and molecular medicine.
[49] Yasuhiko Tabata,et al. Collagenous matrices as release carriers of exogenous growth factors. , 2004, Biomaterials.
[50] Hwal Suh,et al. Sustained release of ascorbate-2-phosphate and dexamethasone from porous PLGA scaffolds for bone tissue engineering using mesenchymal stem cells. , 2003, Biomaterials.
[51] Roland Baron,et al. BMP‐2 Controls Alkaline Phosphatase Expression and Osteoblast Mineralization by a Wnt Autocrine Loop , 2003, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[52] Hua Yang,et al. Biodegradable poly(epsilon-caprolactone)-poly(ethylene glycol) block copolymers: characterization and their use as drug carriers for a controlled delivery system. , 2003, Biomaterials.
[53] T. Park,et al. Dexamethasone-releasing biodegradable polymer scaffolds fabricated by a gas-foaming/salt-leaching method. , 2003, Biomaterials.
[54] Patrick Soon-Shiong,et al. Phase I and pharmacokinetic study of ABI-007, a Cremophor-free, protein-stabilized, nanoparticle formulation of paclitaxel. , 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.
[55] L G Griffith,et al. Effect of pore size and void fraction on cellular adhesion, proliferation, and matrix deposition. , 2001, Tissue engineering.
[56] A. Skoultchi,et al. Coordinating cell proliferation and differentiation. , 2001, Current opinion in genetics & development.
[57] D. Hutmacher,et al. Scaffolds in tissue engineering bone and cartilage. , 2000, Biomaterials.
[58] K. Burg,et al. Biomaterial developments for bone tissue engineering. , 2000, Biomaterials.
[59] M. Kumegawa,et al. Direct stimulation of osteoclastic bone resorption by bone morphogenetic protein (BMP)-2 and expression of BMP receptors in mature osteoclasts. , 2000, Bone.
[60] A. Meunier,et al. Tissue-engineered bone regeneration , 2000, Nature Biotechnology.
[61] E. Burger,et al. Bone morphogenetic proteins in human bone regeneration. , 2000, European journal of endocrinology.
[62] Kohei Miyazono,et al. TGF-β signalling from cell membrane to nucleus through SMAD proteins , 1997, Nature.
[63] K. Chihara,et al. Dexamethasone Stimulates Osteoclast‐like Cell Formation by Directly Acting on Hemopoietic Blast Cells and Enhances Osteoclast‐like Cell Formation Stimulated by Parathyroid Hormone and Prostaglandin E2 , 1997, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[64] S. Bruder,et al. Osteogenic differentiation of purified, culture‐expanded human mesenchymal stem cells in vitro , 1997, Journal of cellular biochemistry.
[65] F. Piquard,et al. Safety and efficacy of a new transpulmonary echo contrast agent in echocardiographic studies in patients. , 1993, Journal of the American College of Cardiology.
[66] P. Speiser,et al. Nanoparticles--a new colloidal drug delivery system. , 1978, Pharmaceutica acta Helvetiae.